Sort by
Refine Your Search
-
Program
-
Field
-
-on expertise in state of the art genetic and epigenetic approaches coupled with next-generation sequencing technologies to gain a broader understanding of MOA and target validation of novel cancer therapeutics
-
preclinical research and advance our clinical and pre-clinical drug programs in the field of cancer cell biology. Our ideal candidate will have a strong background employing state-of-the art approaches to gain
-
research and advance our clinical and pre-clinical drug programs in the field of cancer cell biology. Our ideal candidate will have a strong background employing state-of-the art approaches to gain a broader
-
for processing of mammalian- and bacterial-expressed recombinant protein modalities including, but not limited to multispecific antibodies and conjugation of payloads to the antibodies, using state-of-the-art